Skip to Content

Tenet Healthcare Corp

THC: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$376.00FkzJbcrblj

Tenet Earnings: Boosting 2023 Outlook on Strong Recent Trends

Tenet turned in strong second-quarter results, and management raised its 2023 outlook to recognize these trends. However, even after making mild adjustments to our near-term estimates on these recent results, our fair value estimate of $95 has not changed materially and still remains moderately above recent share prices. Also, while we have a no-moat rating on the firm, we recognize that Tenet's operations have improved substantially in recent years, and we expect returns on invested capital to remain above capital costs throughout our five-year forecast period.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of THC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center